Northwestern Mutual Wealth Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
SCM
WP
Northwestern Mutual Wealth Management's RCUS Position: Q2 2026 in Review
Northwestern Mutual Wealth Management sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 9 shares — an estimated $194 sold.
Northwestern Mutual Wealth Management first reported a position in RCUS in Q2 2021 and held it in 20 quarters. The position peaked at $64K in Q2 2021. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.
- Northwestern Mutual Wealth Management reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 9 Arcus Biosciences shares in Q2 2026, an estimated $194.
- Northwestern Mutual Wealth Management first reported a position in Arcus Biosciences in Q2 2021 and held it in 20 quarters.
- Northwestern Mutual Wealth Management's Arcus Biosciences position peaked at $64K in Q2 2021.
- 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.